Effects of liraglutide, metformin and gliclazide on body composition in patients with both type 2 diabetes and non-alcoholic fatty liver disease: A randomized trial. [electronic resource]
Producer: 20190708Description: 399-407 p. digitalISSN:- 2040-1124
- Adolescent
- Adult
- Aged
- Biomarkers -- analysis
- Blood Glucose -- analysis
- Body Composition -- drug effects
- Diabetes Mellitus, Type 2 -- drug therapy
- Female
- Follow-Up Studies
- Gliclazide -- therapeutic use
- Glycated Hemoglobin -- analysis
- Humans
- Hypoglycemic Agents -- therapeutic use
- Liraglutide -- therapeutic use
- Liver Function Tests
- Male
- Metformin -- therapeutic use
- Middle Aged
- Non-alcoholic Fatty Liver Disease -- drug therapy
- Prognosis
- Prospective Studies
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.